The story of the blue pill offers a complicated case study for investors eyeing pharma. While initial sales were remarkable, present patent lapse and the rise of generic versions have significantly influenced earnings. https://jayayriq940304.frewwebs.com/40119394/viagra-and-big-pharma-a-precarious-investment